wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52638921-6D1C9518-C16A-4419-8F02-04C58DC83AFC
Q52638921-6D1C9518-C16A-4419-8F02-04C58DC83AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52638921-6D1C9518-C16A-4419-8F02-04C58DC83AFC
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
P2860
Q52638921-6D1C9518-C16A-4419-8F02-04C58DC83AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52638921-6D1C9518-C16A-4419-8F02-04C58DC83AFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8295daf4ed5acf90758b0601dec82cb96fdcfeea
P2860
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.